197 related articles for article (PubMed ID: 6462093)
1. Potential role of thymosin in the treatment of autoimmune diseases.
Goldstein AL; Zatz MM; Low TL; Jacobs R
Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
[No Abstract] [Full Text] [Related]
2. Thymosin administration in autoimmune disorders.
Lavastida MT; Goldstein AL; Daniels JC
Thymus; 1981 Feb; 2(4-5):287-95. PubMed ID: 6972106
[TBL] [Abstract][Full Text] [Related]
3. The endocrine thymus: potential role for thymosin in the treatment of autoimmune disease.
Goldstein AL; Thurman GB; Cohen GH; Rossio JL
Ann N Y Acad Sci; 1976; 274():390-401. PubMed ID: 786112
[No Abstract] [Full Text] [Related]
4. Immunocytochemical localization of thymosin-alpha 1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures.
Dalakas MC; Engel WK; McClure JE; Goldstein AL; Askanas V
J Neurol Sci; 1981 May; 50(2):239-47. PubMed ID: 7014787
[TBL] [Abstract][Full Text] [Related]
5. Identification of human thymic epithelial cells with antibodies to thymosin alpha 1 in myasthenia gravis.
Dalakas MC; Engel WK; McClure JE; Goldstein AL; Askanas V
Ann N Y Acad Sci; 1981; 377():477-85. PubMed ID: 7041758
[TBL] [Abstract][Full Text] [Related]
6. Research with immunoactive agents.
Gunby P
JAMA; 1981 Jul; 246(3):205. PubMed ID: 7017181
[No Abstract] [Full Text] [Related]
7. Thymosin alpha 1 in myasthenia gravis.
Dalakas MC; Engel WK; McClure JE; Goldstein AL
N Engl J Med; 1980 May; 302(19):1092-3. PubMed ID: 7366630
[No Abstract] [Full Text] [Related]
8. In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease.
Wara DW; Barrett DJ; Ammann AJ; Cowan MJ
Ann N Y Acad Sci; 1979; 332():128-34. PubMed ID: 161150
[No Abstract] [Full Text] [Related]
9. Appearance of thymosin alpha 1 in supernatants of monocytes incubated with prothymosin alpha.
Frillingos S; Seferiadis K; Papanastasiou M; Baxevanis CN; Frangou-Lazaridis M; Economou M; Papamichail M; Tsolas O
Arch Biochem Biophys; 1992 Jul; 296(1):256-63. PubMed ID: 1534980
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
[TBL] [Abstract][Full Text] [Related]
11. The effect of thymosin alpha1 fragments on T-lymphocyte transformation in the uremic state.
Abiko T; Sekino H; Higuchi H
Chem Pharm Bull (Tokyo); 1980 Nov; 28(11):3411-5. PubMed ID: 6971182
[No Abstract] [Full Text] [Related]
12. T-cell stimulator undergoes diverse testing.
Gunby P
JAMA; 1982 Aug; 248(7):807. PubMed ID: 7047781
[No Abstract] [Full Text] [Related]
13. The effect of thymosin application upon radiation sickness in mice.
Vávrová J; Petýrek P
Folia Biol (Praha); 1976; 22(5):320-9. PubMed ID: 992155
[TBL] [Abstract][Full Text] [Related]
14. [Letter: Antinuclear autoimmunization in Swan mice. Prevention and regression by treatment with thymosin].
Monier JC; Deschaux P; Fontanges R
Nouv Presse Med; 1975 Feb; 4(7):507. PubMed ID: 1079341
[No Abstract] [Full Text] [Related]
15. Overview of thymosin activity.
Marshall GD; Low TL; Thurman GB; Hu SK; Rossio JL; Trivers G; Goldstein AL
Cancer Treat Rep; 1978 Nov; 62(11):1731-7. PubMed ID: 215305
[TBL] [Abstract][Full Text] [Related]
16. [Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].
Grinevich IuA; Kamenets LIa
Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):9-15. PubMed ID: 390944
[No Abstract] [Full Text] [Related]
17. [Principles of immunoregulation in autoimmune syndromes].
Skotnicki AB
Postepy Hig Med Dosw; 1983; 37(4):345-87. PubMed ID: 6233544
[No Abstract] [Full Text] [Related]
18. In vitro and in vivo studies with thymosin in cancer patients.
Schafer LA; Goldstein AL; Gutterman JU; Hersh EM
Ann N Y Acad Sci; 1976; 277(00):609-20. PubMed ID: 136916
[TBL] [Abstract][Full Text] [Related]
19. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.
Goldstein AL
Antibiot Chemother (1971); 1978; 24():47-59. PubMed ID: 350140
[No Abstract] [Full Text] [Related]
20. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
Marshall GD; Thurman GB; Low TL; Goldstein AL
Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
